50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   274.37 (-0.41%)
AAPL   150.77 (+0.23%)
MSFT   237.45 (-0.20%)
META   136.37 (-2.88%)
GOOGL   98.17 (-0.58%)
AMZN   115.15 (+1.20%)
TSLA   276.01 (+0.25%)
NVDA   122.28 (-2.30%)
NIO   17.62 (-0.11%)
BABA   78.91 (+0.14%)
AMD   66.30 (-2.44%)
T   15.67 (-2.12%)
MU   48.88 (-2.44%)
CGC   2.74 (-3.52%)
F   11.99 (-2.60%)
GE   64.35 (-0.31%)
DIS   98.12 (-1.39%)
AMC   6.83 (-14.52%)
PYPL   84.26 (-3.12%)
PFE   43.83 (-0.57%)
NFLX   224.07 (-1.03%)
QQQ   274.37 (-0.41%)
AAPL   150.77 (+0.23%)
MSFT   237.45 (-0.20%)
META   136.37 (-2.88%)
GOOGL   98.17 (-0.58%)
AMZN   115.15 (+1.20%)
TSLA   276.01 (+0.25%)
NVDA   122.28 (-2.30%)
NIO   17.62 (-0.11%)
BABA   78.91 (+0.14%)
AMD   66.30 (-2.44%)
T   15.67 (-2.12%)
MU   48.88 (-2.44%)
CGC   2.74 (-3.52%)
F   11.99 (-2.60%)
GE   64.35 (-0.31%)
DIS   98.12 (-1.39%)
AMC   6.83 (-14.52%)
PYPL   84.26 (-3.12%)
PFE   43.83 (-0.57%)
NFLX   224.07 (-1.03%)
QQQ   274.37 (-0.41%)
AAPL   150.77 (+0.23%)
MSFT   237.45 (-0.20%)
META   136.37 (-2.88%)
GOOGL   98.17 (-0.58%)
AMZN   115.15 (+1.20%)
TSLA   276.01 (+0.25%)
NVDA   122.28 (-2.30%)
NIO   17.62 (-0.11%)
BABA   78.91 (+0.14%)
AMD   66.30 (-2.44%)
T   15.67 (-2.12%)
MU   48.88 (-2.44%)
CGC   2.74 (-3.52%)
F   11.99 (-2.60%)
GE   64.35 (-0.31%)
DIS   98.12 (-1.39%)
AMC   6.83 (-14.52%)
PYPL   84.26 (-3.12%)
PFE   43.83 (-0.57%)
NFLX   224.07 (-1.03%)
QQQ   274.37 (-0.41%)
AAPL   150.77 (+0.23%)
MSFT   237.45 (-0.20%)
META   136.37 (-2.88%)
GOOGL   98.17 (-0.58%)
AMZN   115.15 (+1.20%)
TSLA   276.01 (+0.25%)
NVDA   122.28 (-2.30%)
NIO   17.62 (-0.11%)
BABA   78.91 (+0.14%)
AMD   66.30 (-2.44%)
T   15.67 (-2.12%)
MU   48.88 (-2.44%)
CGC   2.74 (-3.52%)
F   11.99 (-2.60%)
GE   64.35 (-0.31%)
DIS   98.12 (-1.39%)
AMC   6.83 (-14.52%)
PYPL   84.26 (-3.12%)
PFE   43.83 (-0.57%)
NFLX   224.07 (-1.03%)
NASDAQ:PAVM

PAVmed - PAVM Stock Forecast, Price & News

$0.90
-0.08 (-8.16%)
(As of 09/26/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.88
$0.98
50-Day Range
$0.96
$2.31
52-Week Range
$0.82
$9.34
Volume
874,524 shs
Average Volume
1.45 million shs
Market Capitalization
$81.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.67

PAVmed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
529.6% Upside
$5.67 Price Target
Short Interest
Healthy
5.63% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.77
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.89) to ($0.92) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.10 out of 5 stars

Medical Sector

533rd out of 1,069 stocks

Surgical & Medical Instruments Industry

49th out of 104 stocks

PAVM stock logo

About PAVmed (NASDAQ:PAVM) Stock

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Receive PAVM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter.

PAVM Stock News Headlines

Comparing PAVmed (NASDAQ:PAVM) & Asensus Surgical (NYSEAMERICAN:ASXC)
Does PAVmed (NASDAQ:PAVM) Have A Healthy Balance Sheet?
See More Headlines
Receive PAVM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter.

PAVM Company Calendar

Last Earnings
8/16/2022
Today
9/26/2022
Next Earnings (Estimated)
11/28/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PAVM
Fax
N/A
Employees
25
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.67
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+529.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-50,350,000.00
Pretax Margin
-11,912.92%

Debt

Sales & Book Value

Annual Sales
$500,000.00
Book Value
$0.88 per share

Miscellaneous

Free Float
77,713,000
Market Cap
$81.90 million
Optionable
Not Optionable
Beta
0.45

Key Executives

  • Dr. Lishan Aklog M.D. (Age 56)
    Chairman & CEO
    Comp: $1.24M
  • Mr. Dennis M. McGrath CPA (Age 65)
    Pres, CFO & Corp. Sec.
    Comp: $595.6k
  • Dr. Brian J. deGuzman M.D. (Age 57)
    Chief Medical Officer & Exec. VP of Clinical Affairs
    Comp: $427.6k
  • Mr. Shaun M. O'Neil M.B.A. (Age 40)
    Exec. VP & COO
  • Mr. Adrian K. Miller
    VP of Investor Relations













PAVM Stock - Frequently Asked Questions

Should I buy or sell PAVmed stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PAVmed in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PAVM shares.
View PAVM analyst ratings
or view top-rated stocks.

What is PAVmed's stock price forecast for 2022?

2 Wall Street analysts have issued 12 month target prices for PAVmed's stock. Their PAVM share price forecasts range from $3.00 to $9.00. On average, they anticipate the company's share price to reach $5.67 in the next year. This suggests a possible upside of 535.4% from the stock's current price.
View analysts price targets for PAVM
or view top-rated stocks among Wall Street analysts.

How have PAVM shares performed in 2022?

PAVmed's stock was trading at $2.46 at the beginning of the year. Since then, PAVM shares have decreased by 63.7% and is now trading at $0.8918.
View the best growth stocks for 2022 here
.

When is PAVmed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 28th 2022.
View our PAVM earnings forecast
.

How were PAVmed's earnings last quarter?

PAVmed Inc. (NASDAQ:PAVM) released its earnings results on Tuesday, August, 16th. The company reported ($0.17) earnings per share for the quarter.

What other stocks do shareholders of PAVmed own?
What is PAVmed's stock symbol?

PAVmed trades on the NASDAQ under the ticker symbol "PAVM."

Who are PAVmed's major shareholders?

PAVmed's stock is owned by a number of institutional and retail investors. Top institutional investors include Millennium Management LLC (1.80%), State Street Corp (0.37%), Verition Fund Management LLC (0.21%), Northern Trust Corp (0.17%), Occudo Quantitative Strategies LP (0.14%) and RFG Advisory LLC (0.14%). Insiders that own company stock include Lishan Aklog, Matthew Sirovich and Pavmed Inc.
View institutional ownership trends
.

How do I buy shares of PAVmed?

Shares of PAVM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PAVmed's stock price today?

One share of PAVM stock can currently be purchased for approximately $0.89.

How much money does PAVmed make?

PAVmed (NASDAQ:PAVM) has a market capitalization of $81.15 million and generates $500,000.00 in revenue each year. The company earns $-50,350,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis.

How can I contact PAVmed?

PAVmed's mailing address is ONE GRAND CENTRAL PLACE SUITE 4600, NEW YORK NY, 10165. The official website for the company is www.pavmed.com. The company can be reached via phone at (212) 949-4319 or via email at jmh@pavmed.com.

This page (NASDAQ:PAVM) was last updated on 9/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.